These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 1668812

  • 1. Behavioural effects of selective tachykinin agonists in midbrain dopamine regions.
    Stoessl AJ, Szczutkowski E, Glenn B, Watson I.
    Brain Res; 1991 Nov 29; 565(2):254-62. PubMed ID: 1668812
    [Abstract] [Full Text] [Related]

  • 2. Effects of ageing on tachykinin function in the basal ganglia.
    Stoessl AJ, Polanski E, Frydryszak H.
    Brain Res; 1993 Dec 31; 632(1-2):21-8. PubMed ID: 7511976
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological characterization of grooming induced by a selective NK-1 tachykinin receptor agonist.
    Stoessl AJ, Brackstone M, Rajakumar N, Gibson CJ.
    Brain Res; 1995 Nov 27; 700(1-2):115-20. PubMed ID: 8624700
    [Abstract] [Full Text] [Related]

  • 4. The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation.
    Deschamps K, Couture R.
    Br J Pharmacol; 2005 Jul 27; 145(6):712-27. PubMed ID: 15895109
    [Abstract] [Full Text] [Related]

  • 5. Behavioural and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonists.
    Elliott PJ, Mason GS, Stephens-Smith M, Hagan RM.
    Neuropeptides; 1991 Jun 27; 19(2):119-26. PubMed ID: 1719444
    [Abstract] [Full Text] [Related]

  • 6. The NK-3 tachykinin receptor agonist senktide elicits 5-HT-mediated behaviour following central or peripheral administration in mice and rats.
    Stoessl AJ, Dourish CT, Iversen SD.
    Br J Pharmacol; 1988 Jun 27; 94(2):285-7. PubMed ID: 2456111
    [Abstract] [Full Text] [Related]

  • 7. The selective NK3 receptor agonist senktide excites a subpopulation of dopamine-sensitive neurones in the rat substantia nigra pars compacta in vitro.
    Keegan KD, Woodruff GN, Pinnock RD.
    Br J Pharmacol; 1992 Jan 27; 105(1):3-5. PubMed ID: 1375857
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Localization of striatal and nigral tachykinin receptors in the rat.
    Stoessl AJ.
    Brain Res; 1994 May 16; 646(1):13-8. PubMed ID: 7519961
    [Abstract] [Full Text] [Related]

  • 10. The NK-3 tachykinin agonist senktide elicits yawning and chewing mouth movements following subcutaneous administration in the rat. Evidence for cholinergic mediation.
    Stoessl AJ, Dourish CT, Iversen SD.
    Psychopharmacology (Berl); 1988 May 16; 95(4):502-6. PubMed ID: 2463651
    [Abstract] [Full Text] [Related]

  • 11. Characterization and autoradiographic localization of tachykinin receptors in rat gastric fundus.
    Mussap CJ, Burcher E.
    J Pharmacol Exp Ther; 1993 Aug 16; 266(2):1043-53. PubMed ID: 8394903
    [Abstract] [Full Text] [Related]

  • 12. Autoradiographic visualization of NK-3 tachykinin binding sites in the rat brain, utilizing [3H]senktide.
    Stoessl AJ, Hill DR.
    Brain Res; 1990 Nov 26; 534(1-2):1-7. PubMed ID: 1705846
    [Abstract] [Full Text] [Related]

  • 13. Intranigral tachykinin NK3 receptor agonist elicits oral movements in rats.
    Liminga U, Johansson PE, Gunne L.
    Pharmacol Biochem Behav; 1991 Mar 26; 38(3):617-20. PubMed ID: 1712496
    [Abstract] [Full Text] [Related]

  • 14. Classification of tachykinin receptors in muscularis mucosae of opossum oesophagus.
    Daniel EE, Cipris S, Manaka Y, Bowker P, Regoli D.
    Br J Pharmacol; 1989 Aug 26; 97(4):1013-8. PubMed ID: 2477100
    [Abstract] [Full Text] [Related]

  • 15. Comparative behavioural profile of centrally administered tachykinin NK1, NK2 and NK3 receptor agonists in the guinea-pig.
    Piot O, Betschart J, Grall I, Ravard S, Garret C, Blanchard JC.
    Br J Pharmacol; 1995 Nov 26; 116(5):2496-502. PubMed ID: 8581290
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of selective antagonists to dissociate the central cardiovascular and behavioural effects of tachykinins on NK1 and NK2 receptors in the rat.
    Tschöpe C, Picard P, Culman J, Prat A, Itoi K, Regoli D, Unger T, Couture R.
    Br J Pharmacol; 1992 Nov 26; 107(3):750-5. PubMed ID: 1335337
    [Abstract] [Full Text] [Related]

  • 19. Tachykinin NK1 receptor in the guinea-pig isolated proximal urethra: characterization by receptor selective agonists and antagonists.
    Maggi CA, Patacchini R.
    Br J Pharmacol; 1992 Aug 26; 106(4):888-92. PubMed ID: 1327390
    [Abstract] [Full Text] [Related]

  • 20. Substance P-induced cutaneous plasma extravasation in rats is mediated by NK-1 tachykinin receptors.
    Devor M, Papir-Kricheli D, Nachmias E, Rosenthal F, Gilon C, Chorev M, Selinger Z.
    Neurosci Lett; 1989 Aug 28; 103(2):203-8. PubMed ID: 2475833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.